It's time to bring dendritic cell therapy to type 1 diabetes.
about
Metabolism Is Central to Tolerogenic Dendritic Cell FunctionConcise Review: Cell-Based Therapies and Other Non-Traditional Approaches for Type 1 DiabetesToward beta cell replacement for diabetesMinimum information about tolerogenic antigen-presenting cells (MITAP): a first step towards reproducibility and standardisation of cellular therapiesStem cell therapy. Use of differentiated pluripotent stem cells as replacement therapy for treating disease.Effect of dietary gluten on dendritic cells and innate immune subsets in BALB/c and NOD miceImmune interventions to preserve β cell function in type 1 diabetesType 1 diabetes genetic susceptibility and dendritic cell function: potential targets for treatment.Efficient Presentation of Multiple Endogenous Epitopes to Both CD4+ and CD8+ Diabetogenic T Cells for ToleranceDendritic cells and pluripotency: unlikely allies in the pursuit of immunotherapy.Addressing Unmet Medical Needs in Type 1 Diabetes: A Review of Drugs under Development.The Nexus of Stem Cell-Derived Beta-Cells and Genome Engineering.Tolerogenic nanoparticles inhibit T cell-mediated autoimmunity through SOCS2.Directed Differentiation of Human Induced Pluripotent Stem Cells into Dendritic Cells Displaying Tolerogenic Properties and Resembling the CD141+ Subset.MHC-mismatched mixed chimerism restores peripheral tolerance of noncross-reactive autoreactive T cells in NOD mice.Antigen Loading (e.g., Glutamic Acid Decarboxylase 65) of Tolerogenic DCs (tolDCs) Reduces Their Capacity to Prevent Diabetes in the Non-Obese Diabetes (NOD)-Severe Combined Immunodeficiency Model of Adoptive Cotransfer of Diabetes As Well As in NODThe adaptive immune response to cardiac injury-the true roadblock to effective regenerative therapies?Molecular Mechanisms of T Cells Activation by Dendritic Cells in Autoimmune DiseasesHuman mesenchymal stem cells and derived extracellular vesicles induce regulatory dendritic cells in type 1 diabetic patients
P2860
Q26765348-435EFC9F-2840-4418-8FEE-CFE998020024Q28071490-F4BE7097-EA2A-4070-9173-9F764FC11764Q28083650-3EB00F84-D9F3-4282-8DD9-05F4353459E7Q28596281-9A3BF222-EB99-4C3A-8E0C-BB09D8A639B1Q35087066-240E0D57-F23A-484C-AD4A-2BB9D517CE0CQ35147881-E9A3C514-2D06-4ABC-9F1B-C3E3C66A5780Q36520618-D133C50B-EA40-44EE-9518-E67CCC04243EQ37098079-9CE5E859-232E-4CBA-AEB7-5ED93E6629DAQ37717905-259C5406-F69B-4C35-8B9E-99A6E62E1E92Q38453644-4BF197F1-7F7E-4F10-B6ED-FBFF32499C13Q38806457-F6ED29A9-3DF5-491B-9B2B-3B17D4C2620EQ39386163-D65C66FE-6E1D-4CFF-94CC-33049C86B52CQ39665315-232BB030-B94E-4938-8B80-E36896DA0E88Q47550123-CABDAC59-02E4-4A20-85D0-AED20F9F0CE3Q49790362-6ED657EB-E51E-4F76-9CB7-37933F5A661CQ50350123-CCDF1C10-2572-47CD-AEEA-6DC30B488460Q52729626-F618DE58-D219-4F3E-A6C5-FC5E5EC7B578Q56891645-7FF497CF-1254-4C1E-B112-0B26D269F994Q58831417-7F04F410-E777-43A4-81CC-E1739C2EF783
P2860
It's time to bring dendritic cell therapy to type 1 diabetes.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
It's time to bring dendritic cell therapy to type 1 diabetes.
@en
It's time to bring dendritic cell therapy to type 1 diabetes.
@nl
type
label
It's time to bring dendritic cell therapy to type 1 diabetes.
@en
It's time to bring dendritic cell therapy to type 1 diabetes.
@nl
prefLabel
It's time to bring dendritic cell therapy to type 1 diabetes.
@en
It's time to bring dendritic cell therapy to type 1 diabetes.
@nl
P2093
P2860
P356
P1433
P1476
It's time to bring dendritic cell therapy to type 1 diabetes
@en
P2093
C Garrison Fathman
Massimo Trucco
Michael J Clare-Salzler
Nick Giannoukakis
P2860
P356
10.2337/DB13-0886
P407
P50
P5008
P577
2014-01-01T00:00:00Z